《柳葉刀血液學(xué)》是一本專門致力于發(fā)表原創(chuàng)研究的在線雜志，倡導(dǎo)改變或闡明血液學(xué)臨床實(shí)踐，包括但不限于:血液學(xué)-腫瘤學(xué)、紅血球和白細(xì)胞疾病、血小板疾病、干細(xì)胞移植和誘導(dǎo)多能干細(xì)胞以及輸血醫(yī)學(xué)。所有被雜志編輯評(píng)審合格的原創(chuàng)研究將在72小時(shí)內(nèi)進(jìn)行同行評(píng)審，如果被接受，將在提交后8周內(nèi)在網(wǎng)上發(fā)表。該雜志還將發(fā)表相關(guān)評(píng)論和通信。

The Lancet Haematology is an exclusively online journal dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice, including, but not limited to, the subjects of: haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine. All original research judged eligible for consideration by the journal’s editors will be peer-reviewed within 72 h and, if accepted, published online within 8 weeks from submission. The journal will also publish relevant commentary and correspondence.